In 2016, the founder of GPN - Dr. Safadi - had been selected to participate in an intensive program at The Ohio State University (I-Corps@Ohio) to help an earlier firm with which he was associated to move new technology to use-consition. The principals sunsequently spun off GPN Therapeutics, Inc. from that earlier firm now with experience that makes likely that this new firm will move developed products from the lab to the marketplace through public-private partnerships.
